CytoTherapeutics other research news

Patrick Aebischer, a founding scientist of the company, received a five-year, $700,000 grant from the Swiss National Program on Gene Therapy to develop CTII's ciliary neurotrophic factor ( CNTF) for delivery using its CereCRIB implant as a treatment for ALS. ...